168 results on '"Solary, E."'
Search Results
2. Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease
3. The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
4. Developmental changes in human megakaryopoiesis
5. cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
6. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
7. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
8. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
9. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
10. JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
11. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
12. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
13. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
14. ASXL1andSETBP1mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
15. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
16. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
17. Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
18. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
19. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells
20. Cellular localisation of Survivin: impact on the prognosis in colorectal cancer
21. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
22. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
23. An evolutionary perspective on chronic myelomonocytic leukemia
24. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
25. Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
26. Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion
27. Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
28. Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML
29. A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
30. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
31. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation
32. Proteases, proteolysis, and apoptosis
33. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients
34. Prise en charge des cancers solides et des hémopathies malignes du sujet âgé : l'oncogériatrie, une discipline en devenir. Seconde partie : traitement des cancers solides (partie 2) et des hémopathies malignes du sujet âgé
35. Prise en charge des cancers solides et des hémopathies malignes du sujet âgé : l’oncogériatrie une discipline en devenir: Première partie : l’évaluation gériatrique et la prise en charge des cancers solides
36. Heat shock proteins: essential proteins for apoptosis regulation
37. Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes
38. Mitochondria in hematopoiesis and hematological diseases
39. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B
40. Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques
41. Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure
42. Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
43. Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload
44. C020 Prevalence of TET2 mutations in MDS
45. High Concentrations of Intrathecal Interleukin-6 in Human Bacterial and Nonbacterial Meningitis
46. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment.
47. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression.
48. Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms.
49. JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms.
50. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.